These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21371461)

  • 21. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
    Taymans JM; Leysen JE; Langlois X
    J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells.
    Juhasz JR; Hasbi A; Rashid AJ; So CH; George SR; O'Dowd BF
    Eur J Pharmacol; 2008 Mar; 581(3):235-43. PubMed ID: 18237729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer.
    Kong MM; Fan T; Varghese G; O'dowd BF; George SR
    Mol Pharmacol; 2006 Jul; 70(1):78-89. PubMed ID: 16597839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
    Vidi PA; Chemel BR; Hu CD; Watts VJ
    Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
    Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group III metabotropic glutamate receptors and D1-like and D2-like dopamine receptors interact in the rat nucleus accumbens to influence locomotor activity.
    David HN; Abraini JH
    Eur J Neurosci; 2002 Mar; 15(5):869-75. PubMed ID: 11906529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.
    Torvinen M; Kozell LB; Neve KA; Agnati LF; Fuxe K
    J Mol Neurosci; 2004; 24(2):173-80. PubMed ID: 15456930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
    Perreault ML; Shen MY; Fan T; George SR
    Neuroscience; 2015 Jan; 285():194-203. PubMed ID: 25446350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptor homooligomers and heterooligomers in schizophrenia.
    Perreault ML; O'Dowd BF; George SR
    CNS Neurosci Ther; 2011 Feb; 17(1):52-7. PubMed ID: 21199449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
    Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
    Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.
    Lee SP; So CH; Rashid AJ; Varghese G; Cheng R; Lança AJ; O'Dowd BF; George SR
    J Biol Chem; 2004 Aug; 279(34):35671-8. PubMed ID: 15159403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
    Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.